Overview

Definition:
-Skin-sparing mastectomy (SSM) is a surgical procedure that removes the entire breast tissue, including the nipple-areola complex, while preserving the overlying skin envelope for immediate or delayed reconstruction
-This technique aims to achieve oncologic safety with optimal cosmetic results by minimizing skin excision and scar burden compared to traditional mastectomies.
Epidemiology:
-SSM is increasingly performed for early-stage breast cancer and for prophylactic mastectomy in high-risk individuals
-Its adoption has been driven by advances in oncoplastic surgery and breast reconstruction techniques, leading to improved patient satisfaction and quality of life
-The selection of appropriate candidates is crucial for successful outcomes.
Clinical Significance:
-SSM offers a significant advantage in terms of cosmetic outcome and patient acceptance by preserving the skin and subcutaneous tissue, thereby facilitating better breast mound reconstruction
-It allows for a more natural-looking breast shape and can reduce the psychological impact of mastectomy
-It is a cornerstone of modern breast cancer management for select patients.

Indications

Oncologic Indications:
-Early-stage invasive breast cancer or ductal carcinoma in situ (DCIS) with limited skin involvement
-Tumors located away from the nipple-areola complex
-Inflammatory breast cancer is typically a contraindication
-Multi-centric or diffuse DCIS may also be contraindications.
Prophylactic Indications:
-High-risk patients for hereditary breast cancer (e.g., BRCA mutations) with no clinical or radiological evidence of cancer
-Patients with a strong family history of breast cancer and significant personal risk factors.
Patient Factors:
-Patient preference for breast conservation and reconstruction
-Absence of significant comorbidities that would contraindicate prolonged surgery or reconstruction
-Adequate skin quality and absence of prior radiation to the breast.
Contraindications:
-Tumor involving the nipple-areola complex
-Extensive Paget's disease of the nipple
-Inflammatory breast cancer
-Distant metastatic disease
-Previous radiation therapy to the breast
-Large tumor size relative to breast volume
-Active smoking or other factors impairing wound healing.

Preoperative Preparation

Patient Counseling:
-Thorough discussion of the procedure, potential risks, benefits, and alternatives
-Detailed explanation of the reconstruction options (e.g., implant-based, autologous flap)
-Informed consent regarding oncologic safety and cosmetic expectations.
Imaging And Biopsy:
-Complete staging workup, including mammography, ultrasound, and potentially MRI of both breasts
-Biopsy confirmation of malignancy or high-risk lesions
-Sentinel lymph node biopsy planning.
Markings:
-Precise marking of the planned skin incision to encompass the tumor or breast tissue while preserving adequate margins
-Delineation of the nipple-areola complex to be excised
-Planning for mastectomy flap thickness.
Anesthesia Considerations:
-General anesthesia is typically required
-Consideration for adjuncts like regional blocks for postoperative pain management
-Assessment of patient's fitness for prolonged surgical time.

Procedure Steps

Incision And Skin Flaps:
-Elliptical incision around the nipple-areola complex and encompassing the tumor if necessary, or a periareolar incision for prophylactic cases
-Creation of bilateral skin flaps of adequate thickness (typically 0.5-1 cm) to ensure viability and preserve subcutaneous tissue, preserving the dermal vascular plexus.
Mastectomy And Specimen Removal:
-Dissection of the breast tissue off the pectoralis major muscle
-Careful removal of the entire breast parenchyma while maintaining the integrity of the overlying skin flaps
-Specimen orientation for surgical pathology.
Lymph Node Dissection: Performance of sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) as indicated by the oncologic staging and guidelines.
Reconstruction Placement:
-Placement of an implant or tissue expander, or preparation for immediate autologous flap reconstruction, beneath the preserved skin flaps and muscle
-Ensuring adequate coverage and hemostasis.
Closure:
-Meticulous closure of the skin flaps in layers, often with drains placed to manage seroma formation
-Consideration for cosmetic closure techniques.

Postoperative Care

Drain Management:
-Monitoring and management of surgical drains
-Drains are typically removed when output is minimal (e.g., < 30 ml/24h).
Pain Control:
-Adequate analgesia, including multimodal approaches (opioids, NSAIDs, regional blocks) to manage incisional pain and discomfort
-Early mobilization is encouraged.
Wound Care:
-Regular dressing changes, monitoring for signs of infection, flap necrosis, or dehiscence
-Education on self-care and activity restrictions.
Breast Prosthesis And Reconstruction:
-Management of temporary external prostheses if reconstruction is delayed
-Postoperative care related to the chosen reconstruction method (e.g., monitoring flap viability for autologous reconstruction, managing implant-related issues).
Adjuvant Therapy Planning: Discussion and planning of adjuvant therapies (chemotherapy, radiation, endocrine therapy) based on final pathology results, in conjunction with the oncology team.

Complications

Early Complications:
-Seroma formation
-Hematoma
-Wound infection
-Skin flap necrosis
-Nipple-areola complex viability issues.ymphoma
-Drain site issues
-Shoulder stiffness.
Late Complications:
-Implant-related complications (rupture, capsular contracture, asymmetry)
-Poor cosmetic outcome
-Chronic pain
-Lymphedema
-Sensation loss
-Scar hypertrophy.
Prevention Strategies:
-Meticulous surgical technique, especially flap dissection and hemostasis
-Judicious use of drains
-Adequate patient selection and preoperative counseling
-Postoperative antibiotic prophylaxis and early mobilization
-Careful management of reconstruction to minimize tension on flaps.

Prognosis

Factors Affecting Prognosis:
-Stage of cancer at diagnosis
-Histological grade
-Lymph node status
-Receptor status (ER, PR, HER2)
-Patient's overall health
-Adherence to adjuvant therapies.
Outcomes:
-For oncologic indications, the goal is to achieve oncologic safety comparable to traditional mastectomy, with reduced cosmetic deformity
-For prophylactic cases, significant reduction in breast cancer risk is achieved
-Patient satisfaction with cosmetic outcomes is generally high when appropriate candidates are selected.
Follow Up:
-Regular follow-up appointments with the surgical and medical oncology teams
-Clinical breast examinations
-Mammography or MRI of the contralateral breast as per guidelines
-Surveillance for local recurrence or new primary breast cancers.

Key Points

Exam Focus:
-Indications and contraindications for SSM
-Crucial difference between SSM and skin-sparing mastectomy with nipple preservation
-Surgical steps and importance of flap viability
-Management of complications, particularly flap necrosis and seroma
-Role in oncoplastic surgery and prophylactic mastectomy.
Clinical Pearls:
-Always ensure adequate margins and flap thickness
-Counsel patients extensively on realistic cosmetic outcomes and potential for nipple sensation loss
-SLNB is essential for oncologic staging
-Reconstruction choice depends on patient factors and surgeon expertise.
Common Mistakes:
-Inadequate flap thickness leading to necrosis
-Excising too much tissue, negating cosmetic benefits
-Failure to counsel adequately on nipple sensation loss
-Inappropriate patient selection, especially those with contraindications
-Ignoring sentinel node biopsy status.